These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23876895)

  • 1. MiRNA-365 and miRNA-520c-3p respond to risperidone treatment in first-episode schizophrenia after a 1 year remission.
    Liu S; Yuan YB; Guan LL; Wei H; Cheng Z; Han X; Yang L; Pu CC; Yang FD; Lu Z; Deng H; Zhao JP; Yu X
    Chin Med J (Engl); 2013 Jul; 126(14):2676-80. PubMed ID: 23876895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment.
    Song HT; Sun XY; Zhang L; Zhao L; Guo ZM; Fan HM; Zhong AF; Niu W; Dai YH; Zhang LY; Shi Z; Liu XP; Lu J
    J Psychiatr Res; 2014 Jul; 54():134-40. PubMed ID: 24694668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant expression of serum miRNAs in schizophrenia.
    Shi W; Du J; Qi Y; Liang G; Wang T; Li S; Xie S; Zeshan B; Xiao Z
    J Psychiatr Res; 2012 Feb; 46(2):198-204. PubMed ID: 22094284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia.
    Ikeda M; Yamanouchi Y; Kinoshita Y; Kitajima T; Yoshimura R; Hashimoto S; O'Donovan MC; Nakamura J; Ozaki N; Iwata N
    Pharmacogenomics; 2008 Oct; 9(10):1437-43. PubMed ID: 18855532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients.
    Yu HC; Wu J; Zhang HX; Zhang GL; Sui J; Tong WW; Zhang XY; Nie LL; Duan JH; Zhang LR; Lv LX
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():23-9. PubMed ID: 25985888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating miRNA levels in schizophrenia.
    Wei H; Yuan Y; Liu S; Wang C; Yang F; Lu Z; Wang C; Deng H; Zhao J; Shen Y; Zhang C; Yu X; Xu Q
    Am J Psychiatry; 2015 Nov; 172(11):1141-7. PubMed ID: 26183697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom recurrence following intermittent treatment in first-episode schizophrenia successfully treated for 2 years: a 3-year open-label clinical study.
    Emsley R; Oosthuizen PP; Koen L; Niehaus DJ; Martinez G
    J Clin Psychiatry; 2012 Apr; 73(4):e541-7. PubMed ID: 22579160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
    Riedel M; Mayr A; Seemüller F; Maier W; Klingberg S; Heuser I; Klosterkötter J; Gastpar M; Schmitt A; Sauer H; Schneider F; Gaebel W; Jäger M; Möller HJ; Schennach-Wolff R
    World J Biol Psychiatry; 2012 Jan; 13(1):30-8. PubMed ID: 21568628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 gene polymorphisms and response to acute risperidone treatment.
    Kastelic M; Koprivsek J; Plesnicar BK; Serretti A; Mandelli L; Locatelli I; Grabnar I; Dolzan V
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):387-92. PubMed ID: 20060871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Kanno K; Watanabe K; Mashiko H; Niwa S
    Hum Psychopharmacol; 2012 Sep; 27(5):517-20. PubMed ID: 22927115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone in first-episode schizophrenia.
    Cesková E; Prikryl R; Kaspárek T
    Neuro Endocrinol Lett; 2007 Dec; 28(6):811-4. PubMed ID: 18063925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment response in second-episode versus first-episode schizophrenia.
    Emsley R; Oosthuizen P; Koen L; Niehaus D; Martinez L
    J Clin Psychopharmacol; 2013 Feb; 33(1):80-3. PubMed ID: 23277247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced short-term obsessive-compulsive symptoms in schizophrenic patients treated with risperidone: a single-blind prospective study.
    Veznedaroglu B; Ercan ES; Kayahan B; Varan A; Bayraktar E
    Hum Psychopharmacol; 2003 Dec; 18(8):635-40. PubMed ID: 14696023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.